Trygg Pharma Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 3
  • Investments
  • 2

Trygg Pharma General Information

Description

Operator of a late-stage biotechnology company developing omega-3 fatty acids for pharmaceutical applications. The company is engaged in biotechnological research and development, manufacturing and sale of marine-based omega-3 fatty acid concentrate for the nutritional supplements market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • Fjordalléen 16
  • Post Office Box 1423 Vika
  • 0115 Oslo
  • Norway
+47 24 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trygg Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Trygg Pharma‘s full profile, request access.

Request a free trial

Trygg Pharma Executive Team (1)

Name Title Board Seat Contact Info
Aaron Kramer Chief Executive Officer, United States
To view Trygg Pharma’s complete executive team members history, request access »

Trygg Pharma Board Members (4)

Name Representing Role Since
0000 0000 Trygg Pharma Chairman 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Trygg Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Trygg Pharma‘s full profile, request access.

Request a free trial

Trygg Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 01-Jan-2018 000000000 0000 Pharmaceuticals
Epax 01-Dec-2010 Buyout/LBO 000.00 Pharmaceuticals 00000 000000
To view Trygg Pharma’s complete investments history, request access »

Trygg Pharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 01-Jan-2018 000000000 0000 Completed
  • 00000 000000
Epax 01-Dec-2010 Buyout/LBO 000.00 Completed
  • 3 buyers
To view Trygg Pharma’s complete exits history, request access »